NZ595223A - Combinations including pneumococcal serotype 14 saccharide - Google Patents

Combinations including pneumococcal serotype 14 saccharide

Info

Publication number
NZ595223A
NZ595223A NZ595223A NZ59522310A NZ595223A NZ 595223 A NZ595223 A NZ 595223A NZ 595223 A NZ595223 A NZ 595223A NZ 59522310 A NZ59522310 A NZ 59522310A NZ 595223 A NZ595223 A NZ 595223A
Authority
NZ
New Zealand
Prior art keywords
saccharide
pneumococcal serotype
combinations including
including pneumococcal
los
Prior art date
Application number
NZ595223A
Other languages
English (en)
Inventor
Paolo Costantino
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NZ595223A publication Critical patent/NZ595223A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ595223A 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide NZ595223A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16299609P 2009-03-24 2009-03-24
PCT/IB2010/000735 WO2010109325A2 (en) 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide

Publications (1)

Publication Number Publication Date
NZ595223A true NZ595223A (en) 2013-12-20

Family

ID=42352288

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ595223A NZ595223A (en) 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide

Country Status (9)

Country Link
US (1) US20120064104A1 (enExample)
EP (1) EP2411044A2 (enExample)
JP (2) JP5806204B2 (enExample)
CN (1) CN102421449A (enExample)
AU (1) AU2010227221B2 (enExample)
CA (1) CA2756398A1 (enExample)
NZ (1) NZ595223A (enExample)
RU (2) RU2549438C2 (enExample)
WO (1) WO2010109325A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258851A1 (en) 1999-05-19 2010-12-08 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
AR086405A1 (es) 2011-05-17 2013-12-11 Glaxosmithkline Biolog Sa Vacuna de streptococcus pneumoniae
US9427476B2 (en) 2012-05-24 2016-08-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Multivalent meningococcal conjugates and methods for preparing conjugates
NZ630133A (en) * 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
CA2875391A1 (en) 2012-07-27 2014-01-30 Institut National De La Sante Et De La Recherche Medicale Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
CA2937186C (en) * 2014-01-21 2022-11-01 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2015183676A1 (en) * 2014-05-29 2015-12-03 Kapre Subhash V Synthetic peptides as carriers for conjugation with polysaccharides
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2023132795A2 (en) * 2022-01-05 2023-07-13 National University Of Singapore Modified bacterial glycans and conjugates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587398A (en) * 2002-08-02 2012-03-30 Glaxosmithkline Biolog Sa Neisserial bleb preparations and vaccines comprising them
HUE032903T2 (hu) * 2005-12-22 2017-11-28 Glaxosmithkline Biologicals Sa Streptococcus pneumoniae kapszulárispoliszacharid-konjugátumok

Also Published As

Publication number Publication date
RU2011142747A (ru) 2013-04-27
JP5806204B2 (ja) 2015-11-10
US20120064104A1 (en) 2012-03-15
EP2411044A2 (en) 2012-02-01
JP2015163651A (ja) 2015-09-10
JP2012521404A (ja) 2012-09-13
AU2010227221A1 (en) 2011-10-13
AU2010227221B2 (en) 2015-01-22
WO2010109325A2 (en) 2010-09-30
RU2549438C2 (ru) 2015-04-27
CN102421449A (zh) 2012-04-18
CA2756398A1 (en) 2010-09-30
RU2014122163A (ru) 2015-12-10
WO2010109325A3 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
NZ595223A (en) Combinations including pneumococcal serotype 14 saccharide
AR130928A2 (es) Composición inmunogénica
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
MX337933B (es) Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal.
MX389480B (es) Vacuna conjugada neumococica polivalente.
IL217085A0 (en) Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
PT1777236T (pt) Sacáridos modificados possuindo estabilidade melhorada em água para utilização como um medicamento
WO2008020322A3 (en) Combination vaccines with 1-hydroxy-2-phenoxyethane preservative
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
IL191913A0 (en) Pneumococcal polysaccharide conjugate vaccine
MX341778B (es) Goma de mascar natural incluyendo materiales de celulosa.
PH12015500217B1 (en) A capsule for use in a food preparation machine
WO2007116028A3 (en) Conjugate vaccines
IN2009KN04098A (enExample)
WO2008033300A8 (en) Bis (thiohydrazide amides) formulation
WO2012115467A3 (en) Laundry treatment apparatus
WO2013109931A3 (en) Oral product
IN2014DN09791A (enExample)
SG171625A1 (en) Antiseptic-containing silicone elastomers
WO2013160349A3 (en) Cosmetic composition comprising a phosphorylated oligosaccharide and a polysaccharide
UA97359C2 (en) Immunogenic composition
HK1217642A1 (zh) 合成用於绿脓杆菌疫苗的低聚糖
OHMORI Ride in the Steam Locomotive and Long for Old Day
初雪 My Girl
雪梅 JAY CHOU'S STILL FANTASY

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 24 MAR 2017 BY FB RICE

Effective date: 20140327

ERR Error or correction

Free format text: THE OWNER HAS BEEN CORRECTED TO 890887, NOVARTIS AG, LICHTSTRASSE 35, CH-4056 BASEL, CH

Effective date: 20140409

LAPS Patent lapsed